E‐52862—A selective sigma‐1 receptor antagonist, in peripheral neuropathic pain: Two randomized, double‐blind, phase 2 studies in patients with chronic postsurgical pain and painful diabetic neuropathy

Ähnliche Einträge

• Celecoxib‐tramadol co‐crystal in patients with moderate‐to‐severe pain following bunionectomy with osteotomy: Secondary analyses by baseline pain intensity and use of rescue medication of a phase 3, randomized, double‐blind, factorial, active‐ and placebo‐controlled trial
  von: Eugene R. Viscusi, et al.
  Veröffentlicht: (2024)
• Signs of hyperpathia in chronic peripheral neuropathic pain
  von: Malin Erika Carmland, et al.
  Veröffentlicht: (2024)
• Comment on “Pregabalin in patients with post‐traumatic peripheral neuropathic pain: A meta‐analysis of randomized controlled trials”
  von: I‐Wen Chen, et al.
  Veröffentlicht: (2024)
• Prognostic value of preoperative mechanical hyperalgesia and neuropathic pain qualities for postoperative pain after total knee replacement
  von: Andrew D. Vigotsky, et al.
  Veröffentlicht: (2024)
• Characteristics and outcomes of peripheral neuropathic pain patients with repeated applications of high‐concentration capsaicin cutaneous patch: Results of a retrospective chart review in Germany
  von: Kai‐Uwe Kern, et al.
  Veröffentlicht: (2024)